Clinical Trial: Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Randomized, Comparative, Open Label Phase III Trial on Efficacy & Safety of Long-term Treatment With ICL670 Compared to Deferoxamine in Beta-thalassemia Patients With Transfusional

  • Evaluate tolerability profile
  • Estimate absolute and relative change of LIC and Total body iron excretion
  • Evaluation relationship between LIC and potential surrogate markers
  • Evaluate the relationship between pharmacokinetics, pharmacodynamics and safety variable


    • Original Secondary Outcome:

    Information By: Novartis

    Dates:
    Date Received: June 3, 2003
    Date Started: May 2003
    Date Completion:
    Last Updated: April 18, 2012
    Last Verified: April 2012